the future of driver mutations in nsclc
Published 7 years ago • 425 plays • Length 6:04Download video MP4
Download video MP3
Similar videos
-
1:11
dr. belani discusses driver mutations in nsclc
-
1:14
dr. brahmer on targeting driver mutations in nsclc
-
5:29
the role of driver mutations in nsclc treatment - 2022 program: lcvl
-
1:06
dr. garon discusses driver mutations in sclc
-
1:40
dr. portnoy on the importance of driver mutations in the treatment of nsclc
-
4:09
impact of driver mutations in nsclc
-
1:54
dr. perez-soler on the future of lung cancer therapies
-
8:14
approaching non-driver stage iv nsclc
-
3:55
the future of non-driver lung adenocarcinoma
-
16:35
heterogeneity of nsclc and precipitating oncogenic driver mutations
-
1:00
dr. husain on the future of monitoring t790m in lung cancer
-
3:44
what is a driver mutation?
-
7:47
the future of nsclc management
-
4:25
overview of rare driver alterations in nsclc
-
1:08
the role of molecular driver identification continues to expand in nsclc
-
8:03
driver mutations trump pd-l1 expression in lung adenocarcinoma
-
2:19
the future of anti-pd-1 therapies in the nsclc treatment landscape
-
2:40
dr. halmos on met mutations in patients with nsclc
-
1:54
dr. west discusses chemotherapy without driver mutations in nsclc